BCL11A ZFN editing in human cells collected from murine bone marrow at week 19 post-engraftment
Homo sapiens
BCL11A ZFN-edited dual-agent mobilized HSC from an healthy donor were engrafted into immune-deficient NOD scid gamma (NSG) mice. Bone marrow was collected at week 19.